openPR Logo
Press release

Implantable Cardioverter-defibrillators Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

07-11-2017 02:25 PM CET | Health & Medicine

Press release from: Implantable Cardioverter-defibrillators Market

Implantable Cardioverter-defibrillators Market – Global

An ICD or implantable cardioverter-defibrillator is a battery-operated device that is placed under the skin of the patient to monitor the user’s heart rate. ICDs are connected to the heart by thin wires. In cases where an abnormal heart beat is detected, implantable cardioverter-defibrillator deliver an electric shock to reinstate a normal heart rhythm if the patient’s heart is beating too fast. Implantable cardioverter-defibrillators have been useful in thwarting sudden deaths in patients with fibrillation or sustained ventricular tachycardia. Various studies have shown that they may prevent cardiac arrest in patients who are at a high risk of life-threatening ventricular arrhythmias. An implantable cardioverter -defibrillator senses when the heart rhythm is not normal and it tries to make the heart rhythm normal. If the device has a pacemaker feature incorporated, it works as a pacemaker when the heartbeat is slow, and transmit tiny electric signals to the heart. However, when the heartbeat is very chaotic or fast, the device gives defibrillation shocks in order to restrain the abnormal rhythm. Implantable cardioverter-defibrillators work for 24 hours a day.

Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/223

According to Centers for Disease Control and Prevention (CDC), it is estimated that around 2.7–6.1 million individuals in the U.S. suffered from atrial fibrillation in 2015. The report suggests that the number of occurrences is likely to increase with the increase in number of aging of the population in this region. Roughly 2% of the population who are younger than 65 years of age suffers from AF. However, around 9% of the population with 65 years of age or more suffers from AF. Increasing cases of AF among the global population coupled with advancement in technology will drive the implantable cardioverter-defibrillators market during the forecast period.

Implantable Cardioverter-defibrillators Market Taxonomy

On the basis of type of product, the global market is classified into:

Biventricular Implantable Cardioverter Defibrillators
Single Chambered
Dual Chambered

On the basis of type of procedure, the global market is classified into:

Subcutaneous Implantable Cardioverter Defibrillators
Trans-Venous Implantable Cardioverter Defibrillators

On the basis of end user, the global market is classified into:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others

The subcutaneous ICD (S-ICD) is inserted without placing the leads into the heart. The device is inserted below the left axilla, or armpit in line with the rib cage. The lead connected to the device is laired under the skin more willingly than inside the heart. Some of the advantages of the S-ICD are the lack of immediate or long-term complications caused by inserting a lead into the heart, such as collapse of the lung and perforation of the heart. Subcutaneous implantable cardioverter defibrillators are the main driver for the global ICD market due to the aforementioned reasons. The rise in adoption of S-ICDs will propel the overall implantable cardioverter-defibrillators market in the forecast period.

High prevalence of arrhythmia will drive the overall implantable cardioverter-defibrillators market

The rising old age population and high occurrence of coronary artery diseases are some of the major factors which will propel growth of the implantable cardioverter-defibrillators market. Sedentary lifestyles, unhealthy dietary habits, and lack of proper exercise have resulted into the increased incidences of heart related diseases, especially arrhythmia. The demand for ICDs is rising significantly as healthcare professionals and the governing bodies such as American Heart Association have widely accepted this form of treatment due to its safety, and efficacy. However, the AHA recommends that the arrhythmia in question ought to be life threatening for the patient to be eligible for a cardioverter defibrillator.

North America held the maximum market share in implantable cardioverter defibrillator market globally. Favorable and constructive policies and regulations as well as availability of sophisticated healthcare facilities along with rising approvals about the usage of implantable cardioverter-defibrillators from the governing bodies are likely to fuel the growth of the implantable cardioverter-defibrillators industry in this region.

Some of the key players operating in the global implantable cardioverter-defibrillators market are Imricor Medical Systems, Boston Scientific Corporation, Inc., LivaNova PLC Company, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, St. Jude Medical, Inc., and MRI Interventions, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Cardioverter-defibrillators Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024 here

News-ID: 617056 • Views:

More Releases for ICD

ICD-10 Market Plying for Significant Growth During 2016-2026
International Classification of Diseases (ICD) -10 is a new system, launched in October 2015 by the World Health Organization (WHO). It classifies and monitors diseases, their symptoms, and track causes of injury and abnormal findings. ICD-10 uses codes to classify the diseases. These codes are used to provide better information of diseases thus helping in improving the quality of patient care. For instance, data captured by ICD-10 can help to
ICD-10 Market to Perceive Substantial Growth During 2016-2026
International Classification of Diseases (ICD) -10 is a new system, launched in October 2015 by the World Health Organization (WHO). It classifies and monitors diseases, their symptoms, and track causes of injury and abnormal findings. ICD-10 uses codes to classify the diseases. These codes are used to provide better information of diseases thus helping in improving the quality of patient care. For instance, data captured by ICD-10 can help to
ICD Code Converter Now Available
Clearwater, FL- EON Systems, Inc., the provider of The Digital Office™, a complete software suite for healthcare providers, is excited to announce the launch of its ICD Converter App. The company’s new product, which launched on October 31st, 2014, is available on all Android®, iPad® and iPhone® products. EON’s ICD Converter app features both ICD-9 to ICD-10 conversion and ICD-10 to ICD-9 conversion. In addition
Career Step Releases Its New ICD-10 FastTrack Course
PROVO, Utah—September 20, 2013— Career Step, an online school offering career-focused education, is pleased to announce the release of its new ICD-10 FastTrack course, which is designed to prepare ICD-9 trained and experienced medical coders for the October 1, 2014 transition to the ICD-10 code set. This streamlined program was developed in collaboration with renowned industry experts Ann Zeisset, RHIT, CCS, CCS-P, and Gail Smith, MA, RHIA, CCS-P, as well
Career Step Launches ICD-10-CM/ICD-10-PCS Code Set Training at HIMSS13
PROVO, Utah—March 4, 2013— Career Step, an online education company, is pleased to announce the launch of its ICD-10-CM and ICD-10-PCS code set training at the HIMSS13 Annual Conference & Exhibit. The courses are available through Career Step’s ICD-10 education offering, The ICD-10 Solution, developed in partnership with YES HIM Consulting, Inc., a firm specializing in ICD-10 preparation since 2009. “As healthcare providers move through their ICD-10 transition plans, ICD-10 code
Avior Computnig Releases ICD-10 Knowledge Module
Avior Computing Corporation, a leader in automated risk and compliance management, announced today the immediate availability of an ICD-10 Knowledge Module for the firm’s BenchMark compliance management solutions. The ICD-10 Knowledge Module provides all the content for the Avior BenchMark v6 platform, also released today, to streamline management of the complex interactions between health plans and healthcare providers and their trading partners. Avior’s ICD-10 Knowledge Module is currently in production use